Last $1.50 USD
Change Today 0.00 / 0.00%
Volume 540.8K
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey L. Wade J.D.

Chief Financial Officer and Executive Vice President of Corporate Development, Lexicon Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

49$973,640
As of Fiscal Year 2013

Background*

Mr. Jeffrey L. Wade, J.D. has been the Chief Financial Officer of Lexicon Genetics Inc. (also known as Lexicon Pharmaceuticals, Inc) since May 2010 and its Executive Vice President of Corporate Development since May 2010. Mr. Wade served as an Executive Vice President and General Counsel of Lexicon Genetics Inc. since February 2000 and also served as its Secretary. He served as Senior Vice President and Chief Financial Officer of Lexicon Genetics Inc. from January 1999 ...

Read Full Background

Corporate Headquarters*

8800 Technology Forest Place
The Woodlands, Texas 77381

United States

Phone: 281-863-3000
Fax: 281-863-8088

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD
The University of Texas System
BA
The University of Texas System

Other Affiliations*

Annual Compensation*

Salary$391,667
Total Annual Compensation$391,667

Stock Options*

Restricted Stock Awards$142,120
All Other Compensation$6,938
Exercisable Options1,739,628
Exercisable Options Value$156,339
Unexercisable Options554,372
Unexercisable Options Value$2,911
Total Value of Options$159,250
Total Number of Options2,294,000

Total Compensation*

Total Annual Cash Compensation$398,605
Total Short Term Compensation$391,667
Other Long Term Compensation$149,058
Total Calculated Compensation$973,640
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $1.50 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.